Related Experiment Video
Updated: Aug 16, 2025

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Molecular mechanisms of multidrug resistance in clinically relevant enteropathogenic bacteria (Review)
Julia Alexsandra González-Villarreal1, Katia Jamileth González-Lozano2, Elva Teresa Aréchiga-Carvajal2
1Faculty of Biological Sciences, Autonomous University of Coahuila, Torreón, Coahuila 27275, Mexico.
Abstract:
Multidrug resistant (MDR) enteropathogenic bacteria are a growing problem within the clinical environment due to their acquired tolerance to a wide range of antibiotics, thus causing severe illnesses and a tremendous economic impact in the healthcare sector. Due to its difficult treatment, knowledge and understanding of the molecular mechanisms that confer this resistance are needed. The aim of the present review is to describe the mechanisms of antibiotic resistance from a genomic perspective observed in bacteria, including naturally acquired resistance. The present review also discusses common pharmacological and alternative treatments used in cases of infection caused by MDR bacteria, thus covering necessary information for the development of novel antimicrobials and adjuvant molecules inhibiting bacterial proliferation.
Insights
Multidrug resistant (MDR) bacteria pose a significant clinical challenge. This review explores their genomic resistance mechanisms and treatment strategies for developing new antimicrobials.
Area of Science:
- Microbiology
- Genomics
- Pharmacology
Background:
- Multidrug resistant (MDR) enteropathogenic bacteria present a growing clinical challenge.
- Their acquired tolerance to antibiotics leads to severe illnesses and significant healthcare costs.
- Understanding MDR mechanisms is crucial for effective treatment and control.
Purpose of the Study:
- To review the genomic mechanisms of antibiotic resistance in bacteria, including naturally acquired resistance.
- To discuss current pharmacological and alternative treatments for MDR bacterial infections.
- To provide information for developing novel antimicrobials and adjuvant therapies.
Main Methods:
- Genomic analysis of antibiotic resistance mechanisms.
- Literature review of pharmacological and alternative treatments.
- Synthesis of information for antimicrobial development.
Main Results:
- Detailed description of genomic basis for MDR in enteropathogenic bacteria.
- Overview of existing treatment options for MDR infections.
- Identification of targets for novel antimicrobial development.
Conclusions:
- Genomic insights are vital for combating MDR bacteria.
- A combination of established and novel treatments is necessary.
- Further research into antimicrobial and adjuvant molecule development is essential.
More Related Videos
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
08:32Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Related Concept Videos
Development of Antibiotic Resistance
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents